JPMorgan analyst Lisa Gill raised the firm’s price target on U.S. Physical Therapy (USPH) to $120 from $117 and keeps an Overweight rating on the shares. The firm updated healthcare facilities models post the Q3 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on USPH:
- U.S. Physical Therapy acquires eight-clinic hand & physical therapy practice
- U.S. Physical Therapy management to meet with Barrington
- US Physical Therapy Executives to Present at Conferences
- U.S. Physical Therapy Reports Strong Q3 2024 Growth
- U.S. Physical Therapy reports Q3 adjusted EPS 55c, consensus 68c